In this video, Nancy S. Reau, MD, FAASLD, AGAF, discusses 36-month results from the ongoing phase 3 ASSURE open-label extension trial of Livdelzi in patients with primary biliary cholangitis.“Earlier ...
WINSTON-SALEM — Novant Health is the first health care system in the Carolinas to offer histotripsy, a groundbreaking ...
Two new clinical trials show that microbubble ultrasound contrast agents safely and effectively improve liver tumor responses to radiotherapy and patient survival, according to results announced today ...
Virginians now have access to a new noninvasive liver cancer treatment. UVA Health in Charlottesville is the first hospital in the state to treat liver tumors with histotripsy, an incisionless ...
GENOA, Italy and FISHERS, Ind. , Aug. 22, 2025 /PRNewswire/ -- Esaote – one of the world's leading medical imaging companies - is proud to announce that the MyLab™ A50 and MyLab™ A70 ultrasound ...
HOUSTON, Aug. 8, 2025 /PRNewswire/ -- Memorial Hermann-Texas Medical Center announced today that it will begin using a new FDA-approved ultrasound device to perform targeted, non-invasive treatment of ...
Liver cirrhosis is associated with serious complications of portal hypertension (PH), which ultimately causes variceal bleeding and ascites in a life-threatening manner. Non-invasive diagnostic ...
CHICAGO--(BUSINESS WIRE)--Patients with liver diseases will have expanded access to advanced ultrasound imaging and transplant options, thanks to new policy allowing doctors to use contrast-enhanced ...
Introduction The imbalance between the demand for liver transplants and the shortage of donors can be addressed by expanding the donor pool, including using extended criteria donors. This strategy may ...
Products mentioned in the material may be subject to government regulations and may not be available in all countries. Please check with local GE HealthCare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback